Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TAUOPATHY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TAUOPATHY is a concept in neurodegeneration research. Key relationships include: activates, associated with, inhibits. Associated with ALS, Aging, Als. Connected to 436 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | TAUOPATHY |
| Key Genes/Proteins | ABCA1, ACHE, Actin, ADNP, AGING, AKT |
| Related Diseases | Aging, Als, ALS, Alzheimer |
| Related Pathways | Akt, Alpha-Synuclein |
Knowledge base pages for this entity
graph TD
TAUOPATHY["TAUOPATHY"]
TAUOPATHY -->|"causes"| lipid_droplets["lipid droplets"]
TAUOPATHY -->|"activates"| ALS["ALS"]
TAUOPATHY -->|"activates"| Neurodegeneration["Neurodegeneration"]
TAUOPATHY -->|"activates"| Alzheimer["Alzheimer"]
TAUOPATHY -->|"activates"| Tauopathy["Tauopathy"]
TAUOPATHY -->|"expressed in"| Aging["Aging"]
TAUOPATHY -->|"expressed in"| Dementia["Dementia"]
JUN["JUN"] -->|"target for"| TAUOPATHY
APOE["APOE"] -->|"activates"| TAUOPATHY
ABCA1["ABCA1"] -->|"target for"| TAUOPATHY
RAB7A["RAB7A"] -->|"activates"| TAUOPATHY
CHMP6["CHMP6"] -->|"activates"| TAUOPATHY
RAB35["RAB35"] -->|"activates"| TAUOPATHY
BMAL1["BMAL1"] -->|"inhibits"| TAUOPATHY
BAG3["BAG3"] -->|"activates"| TAUOPATHY
CLOCK["CLOCK"] -->|"activates"| TAUOPATHY
TYROBP["TYROBP"] -->|"expressed in"| TAUOPATHY| Target | Relation | Type | Str |
|---|---|---|---|
| Tauopathy | activates | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Tauopathy | associated_with | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Tauopathy | expressed_in | disease | 0.95 |
| Als | activates | disease | 0.95 |
| Als | associated_with | disease | 0.95 |
| Tauopathy | therapeutic_target | disease | 0.85 |
| Alzheimer | therapeutic_target | disease | 0.85 |
| Tauopathy | regulates | disease | 0.85 |
| lipid accumulation | causes | phenotype | 0.85 |
| Inflammation | activates | disease | 0.85 |
| Tauopathy | inhibits | disease | 0.85 |
| Microtubule | causes | protein | 0.85 |
| oxidative stress response | involves | pathway | 0.85 |
| Senescent Microglia | associated_with | cell_type | 0.80 |
| MICROGLIA | regulates | gene | 0.80 |
| AUTOPHAGY | activates | gene | 0.80 |
| unfolded protein response | involves | pathway | 0.75 |
| autophagy pathway | involves | pathway | 0.75 |
| Alzheimer | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Huntington | activates | disease | 0.75 |
| Neuroinflammation | activates | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| Dementia | associated_with | disease | 0.75 |
| Neurodegeneration | regulates | disease | 0.75 |
| Tauopathy | interacts_with | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Neurodegeneration | inhibits | disease | 0.75 |
| Inflammation | treats | disease | 0.75 |
| Neuroinflammation | treats | disease | 0.75 |
| Alzheimer | inhibits | disease | 0.75 |
| Alzheimer | treats | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Neuroinflammation | regulates | disease | 0.75 |
| Inflammation | regulates | disease | 0.75 |
| Alzheimer | causes | disease | 0.75 |
| Dementia | expressed_in | disease | 0.75 |
| Alzheimer | expressed_in | disease | 0.75 |
| Als | causes | disease | 0.75 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| TAU | activates | gene | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| TAUOPATHY | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| TAU | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| ALZHEIMER | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| TAU | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| TAUOPATHY | associated_with | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| TAUOPATHY | expressed_in | gene | 0.95 |
| AUTOPHAGY | activates | gene | 0.95 |
| TAU | biomarker_for | protein | 0.95 |
| MAPT | causes | gene | 0.95 |
| MAPT | associated_with | gene | 0.95 |
| TFEB | therapeutic_target | gene | 0.90 |
| TAU | associated_with | gene | 0.90 |
| NRF2 | therapeutic_target | protein | 0.90 |
| TRIAD3A | protects_against | protein | 0.90 |
| Lipid Droplet Accumulation | associated_with | phenotype | 0.90 |
| Ps19 Mouse Model | associated_with | disease | 0.90 |
| 9H6F2 Antibody | biomarker_for | biomarker | 0.88 |
| TAUOPATHY | regulates | gene | 0.85 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.85 |
| APP E590D | exacerbates | protein | 0.85 |
| TAU | therapeutic_target | gene | 0.85 |
| Als | associated_with | disease | 0.85 |
| TYROBP Deficiency | protects_against | phenotype | 0.85 |
| MICROGLIA | regulates | gene | 0.85 |
| TAUOPATHY | therapeutic_target | gene | 0.85 |
| Neuroinflammation | interacts_with | process | 0.85 |
| ALZHEIMER | therapeutic_target | gene | 0.85 |
| NEURODEGENERATION | regulates | gene | 0.85 |
| TAU PATHOLOGY | therapeutic_target | gene | 0.85 |
| TAUOPATHY | inhibits | gene | 0.85 |
| ALZHEIMER'S DISEASE | inhibits | gene | 0.85 |
| Tau Inclusions | biomarker_for | phenotype | 0.85 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TREM2 Antagonism in Late-Stage Tauopathy — Reducing Neuroinf | 0.628 | Alzheimer's disease | TREM2 agonism vs antagonism in DAM micro |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-09 | 0 hypotheses
drug discovery | 2026-04-09 | 0 hypotheses
neurodegeneration | 2026-04-08 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |
| Role of TREM2 in neuroinflammation. [PMID:41213496] | Abdulkhaliq AA, Alasiri G, Almoghrabi Y, | Exp Neurol | 2026 | 0 |
| Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] | Zhang J, St Pierre Schneider B, Muguerza | Am J Physiol Endocrinol Metab | 2026 | 0 |
| Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] | Mateus-Tique J, Lakshmi A, Singh B, Iyer | Cancer Cell | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] | Feiten AF, Dahm K, Schlepckow K, van Len | Nat Commun | 2026 | 0 |
| Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] | Xia P, Shuang S, Fu D, Liu L, Yang D et | NPJ Precis Oncol | 2026 | 0 |
| Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] | Zhao Q, Huang R, Wang C, Hu J, Nie R et | Cancer Cell | 2026 | 0 |
| TREM2 in neurodegeneration and diseases. [PMID:41792456] | ["Abdulkhaliq A", "Alasiri G", "Kim B", | Molecular psychiatry | 2026 | 0 |
| Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] | Aranda-Abreu GE, Rojas-Durán F, Hernánde | Neurology international | 2026 | 0 |
| Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] | Alhusaini M, Mussa BM, Ilce BY, Alhaj H, | Frontiers in aging neuroscienc | 2026 | 0 |
| Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] | ["Srivastav Jyotsna", "Sharma Sachin"] | Frontiers in medicine | 2025 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 7 · Score: 0.95 · 2026-04-10
closed · Rounds: 4 · Score: 0.86 · 2026-04-10
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
Hypotheses and analyses mentioning TAUOPATHY in their description or question text
No additional research found